Follow
Sandra Furlanetto
Sandra Furlanetto
Professore Associato di Chimica Analitica (CHIM/01) Universitŕ di Firenze
Verified email at unifi.it - Homepage
Title
Cited by
Cited by
Year
Application of quality by design to the development of analytical separation methods
S Orlandini, S Pinzauti, S Furlanetto
Analytical and bioanalytical chemistry 405, 443-450, 2013
2492013
Utilization of differential scanning calorimetry as a screening technique to determine the compatibility of ketoprofen with excipients
P Mura, A Manderioli, G Bramanti, S Furlanetto, S Pinzauti
International Journal of Pharmaceutics 119 (1), 71-79, 1995
1791995
Simultaneous liquid chromatographic analysis of catecholamines and 4-hydroxy-3-methoxyphenylethylene glycol in human plasma: comparison of amperometric and coulometric detection
C Sabbioni, MA Saracino, R Mandrioli, S Pinzauti, S Furlanetto, G Gerra, ...
Journal of Chromatography A 1032 (1-2), 65-71, 2004
1442004
Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-β-cyclodextrin-PVP complex
N Mennini, S Furlanetto, M Cirri, P Mura
European journal of Pharmaceutics and Biopharmaceutics 80 (1), 67-75, 2012
1362012
LC coupled to ion-trap MS for the rapid screening and detection of polyphenol antioxidants from Helichrysum stoechas
M Carini, G Aldini, S Furlanetto, R Stefani, RM Facino
Journal of pharmaceutical and biomedical analysis 24 (3), 517-526, 2001
1342001
Influence of the preparation method on the physicochemical properties of ketoprofen–cyclodextrin binary systems
P Mura, MT Faucci, PL Parrini, S Furlanetto, S Pinzauti
International journal of pharmaceutics 179 (1), 117-128, 1999
1331999
Validation of a RP-LC method for the simultaneous determination of isoniazid, pyrazinamide and rifampicin in a pharmaceutical formulation
E Calleri, E De Lorenzi, S Furlanetto, G Massolini, G Caccialanza
Journal of pharmaceutical and biomedical analysis 29 (6), 1089-1096, 2002
1222002
Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives
L Filippi, G Cavallaro, P Bagnoli, M Dal Monte, P Fiorini, G Donzelli, ...
The Journal of pediatrics 163 (6), 1570-1577. e6, 2013
1122013
Characterization of physicochemical properties of naproxen systems with amorphous β-cyclodextrin-epichlorohydrin polymers
P Mura, MT Faucci, F Maestrelli, S Furlanetto, S Pinzauti
Journal of pharmaceutical and biomedical analysis 29 (6), 1015-1024, 2002
1102002
Multivariate optimization of capillary electrophoresis methods: a critical review
S Orlandini, R Gotti, S Furlanetto
Journal of Pharmaceutical and Biomedical Analysis 87, 290-307, 2014
1072014
Didanosine extended-release matrix tablets: optimization of formulation variables using statistical experimental design
C Sánchez-Lafuente, S Furlanetto, M Fernández-Arévalo, ...
International journal of pharmaceutics 237 (1-2), 107-118, 2002
1042002
Analysis of catechins in Theobroma cacao beans by cyclodextrin-modified micellar electrokinetic chromatography
R Gotti, S Furlanetto, S Pinzauti, V Cavrini
Journal of Chromatography A 1112 (1-2), 345-352, 2006
1022006
Identification and determination of mainstream and sidestream smoke components in different brands and types of cigarettes by means of solid-phase microextraction–gas …
G Pieraccini, S Furlanetto, S Orlandini, G Bartolucci, I Giannini, S Pinzauti, ...
Journal of chromatography A 1180 (1-2), 138-150, 2008
982008
Study of formulation variables influencing the drug release rate from matrix tablets by experimental design
S Furlanetto, M Cirri, F Maestrelli, G Corti, P Mura
European journal of pharmaceutics and biopharmaceutics 62 (1), 77-84, 2006
952006
Simultaneous effect of cyclodextrin complexation, pH, and hydrophilic polymers on naproxen solubilization
M Cirri, F Maestrelli, G Corti, S Furlanetto, P Mura
Journal of pharmaceutical and biomedical analysis 42 (1), 126-131, 2006
872006
Development and characterization of functionalized niosomes for brain targeting of dynorphin-B
M Bragagni, N Mennini, S Furlanetto, S Orlandini, C Ghelardini, P Mura
European Journal of Pharmaceutics and Biopharmaceutics 87 (1), 73-79, 2014
852014
Experimental design in the development of voltammetric method for the assay of omeprazole
S Pinzauti, P Gratteri, S Furlanetto, P Mura, E Dreassi, R Phan-Tan-Luu
Journal of pharmaceutical and biomedical analysis 14 (8-10), 881-889, 1996
821996
Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491
L Filippi, G Cavallaro, P Fiorini, M Daniotti, V Benedetti, G Cristofori, ...
BMC pediatrics 10, 1-11, 2010
812010
Oral topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia: a safety study
L Filippi, C Poggi, G la Marca, S Furlanetto, P Fiorini, G Cavallaro, ...
The Journal of pediatrics 157 (3), 361-366, 2010
792010
Determination of aminorex in human urine samples by GC–MS after use of levamisole
E Bertol, F Mari, MG Di Milia, L Politi, S Furlanetto, SB Karch
Journal of pharmaceutical and biomedical analysis 55 (5), 1186-1189, 2011
772011
The system can't perform the operation now. Try again later.
Articles 1–20